Are you interested in helping the Center for Excellence in Youth Education (CEYE) increase diversity in science and medicine by mentoring students in high school and college? If so, you would be joining the more than 100 Mount Sinai physicians, scientists, nurses, social workers, lab technicians, residents, and postdoctoral students who have invited students to shadow them in their jobs over the last two years. The students are selected after a competitive application process and must maintain a B average throughout the duration of the program. CEYE is sponsored by the Center for Multicultural and Community Affairs at Icahn School of Medicine at Mount Sinai. To learn more, contact Alyson Davis, MSW, at 212-241-7655 or firstname.lastname@example.org.
It was a “miracle on 125th Street” last December, when Cecil Williams, who is blind, temporarily lost consciousness and fell onto the subway tracks at the Harlem station with his loyal service dog Orlando close behind. Onlookers frantically summoned help. Together, the two survived in the space between the tracks as the train pulled in above them.
Suffering from cuts and bruises, and a laceration to his head, Mr. Williams was treated at St. Luke’s Hospital for nine days before being released. Orlando was always at his side.
The Mount Sinai Department of Radiation Oncology is now treating patients with superficial non-melanoma skin cancers such as squamous cell and basal cell carcinomas, and keloids, with a non-invasive and painless procedure, Superficial Radiotherapy. The procedure utilizes superficial x-rays that concentrate radiation dose on the skin surface. There are several advantages of using superficial radiation therapy to treat non-melanoma skin cancers and keloids, including:
Richard Rosen, MD, Vice Chair of the Department of Ophthalmology at New York Eye and Ear Infirmary, and a team of researchers in the Shelley and Steven Einhorn Clinical Research Center, are pioneering an imaging technology that enables them to see microscopic details of the retina and its finest blood vessels at a level not previously possible in patients with sight–threatening disease.
The Icahn School of Medicine at Mount Sinai, and National Jewish Health, the nation’s leading respiratory hospital, based in Denver, Colorado, have created a partnership to advance patient care and research in respiratory and related diseases. The Mount Sinai–National Jewish Health Respiratory Institute is expected to open on the Icahn School of Medicine campus in July.
The Mount Sinai Health System recently established the Mount Sinai Institute of Technology (MSIT), with a $5 million grant from the New York City Economic Development Corporation (NYCEDC). As part of Icahn School of Medicine at Mount Sinai, MSIT will train students to develop technology-based solutions that improve human health, and serve as an incubator for transformative, cost-effective discoveries.
This year, the Mount Sinai Global Women’s Health team visited Botswana, Africa and the Dominican Republic. I had the privilege of being invited to my first Global Women’s Health mission in the Dominican Republic. The trip was extremely rewarding and successful. The team, led by the Director of Global Women’s Health, Dr. Tareneh Shirazian, assisted over 600 women in desperate need of care.
In recognition of Diabetes Awareness Month in November, the Mount Sinai Diabetes Center hosted an educational event for patients, staff, and the community in the Guggenheim Atrium on how to prevent and control diabetes. It included “Viva Fitness” demonstrations and tastings by the Food and Nutrition Department.
There are more than 23 million people in the United States, including 1.6 million in New York State, who have type 2 diabetes, which occurs when the body is resistant to the action of insulin, a hormone produced by the pancreas to lower the blood sugar. Type 2 diabetes, which is often associated with obesity, can result in kidney failure, limb amputations, blindness, heart disease, and stroke when blood sugar levels are uncontrolled.
“Many of these individuals who are living with type 2 diabetes and obesity are trying tirelessly to manage their diabetes and blood sugar, but without success,” says Aida Saliby, MD, of the Department of Endocrinology at Beth Israel Medical Center. “They do not respond fully to diet and lifestyle modifications, or they become resistant to the effects of oral medications, requiring additional treatments to manage their disease. Given the severe and growing diabetes epidemic, there is a substantial need to develop new, more effective therapies,” she says.